ReGenesys is a subsidiary of Athersys, Inc., a biotechnology company in Cleveland, USA. The company is developing MultiStem® cell therapy, a patented, adult-derived, “off-the-shelf” stem cell product. ReGenesys is focused on the R&D that supports the MultiStem® clinical programs and is developing potential new regenerative medicine opportunities, such as animal health care.
Company Details
- Employees
- 1
- Founded
- 2005
- Address
- Gaston Geenslaan 1, Heverlee,3001,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://regenesys.eu/
- HQ
- Heverlee
Regenesys Bv Questions
Regenesys Bv's website is https://regenesys.eu/
Regenesys Bv's LinkedIn profile is https://be.linkedin.com/company/regenesys-bv-be
Regenesys Bv has
1 employees.
View email and phone details for 1
employees at Regenesys Bv.
Regenesys Bv's industry is
Biotechnology Research
Regenesys Bv's top competitors are
Paul Dick & Associates Ltd.,
Diah Conference,
Fishway,
Benno Therapeutics,
Apitope,
Alpha Regenesys,
Ucb,
Biopolymer International,
Harpago,
Regenesys Consulting Inc..
Regenesys Bv's categories are Biotechnology Research
Regenesys Bv's founding year is 2005
